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 Cancer affects everyone 
Economic impact of cancer in 2007 
Total : $226.8 billion  
Direct medical costs : $103.8 billion  
Indirect mortality costs : $123.0 billion 
Source: NIH, American Cancer Society website (www.cancer.org) Colon cancer is the second 
leading cause of cancer death 
• In 2011, nearly 50,000 deaths in the 
U.S., many of which were 
preventable 
• 5-year survival rates range from 
6%-74% 
• Early detection is vital Factors that increase cancer 
risk 
• Mutations in critical genes 
Mismatch repair deficiency 
(Lynch syndrome) 
• Exposure to carcinogens 
Polycyclic aromatic 
hydrocarbon (PAH) exposure Mismatch repair 
   
• Highly conserved pathway focused 
on repair of DNA replication errors 
• Conserved proteins include MLH1, 
PMS2, MSH2, MSH6 
• MMR deficiency has significant 
impacts on human health 
(increased cancer risk)  
 MMR recognizes and repairs DNA 
replication errors 
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MutSα  MutLα PAHs – they’re everywhere Many studies link PAHs to cancer 
• Scrotal tumors in chimney sweeps 
• Lung cancers in smokers 
• Colon cancer associated with grilled meat 
consumption 
• Coal-tar induced skin tumors (mice) 
• In utero PAH exposure linked to cancer 
as adult in mice PAHs vary in structure and  
carcinogenicity 
(From Neff, 1979; CCREM, 1987; NRCC, 1983; USPHS, 1990) 
Anthracene  Fluorene 
Dibenzo(a,l)pyrene  Perylene  Chrysene 
Benzo[a]pyrene Benzo[a]pyrene – a model PAH 
• Best known and most studied of PAHs 
• Gold standard of PAH carcinogenicity 
• Produced during combustion of organic 
compounds 
• Recalcitrant pollutant - bioaccumulates 
• Detected in air, water, food and soil 
 BaP content of some foods* 
Sample  PPB (ng/g) 
BBQ steak, very well done  4.75 
BBQ chicken (bone and skin), well done  4.57 
BBQ hamburger, medium cooked  0.56 
Pumpkin pie  0.47 
Fast food french fry  0.22 
Tomato (fresh)  0.19 
*Kazerouni N., Sinha R., Hsu C.-H., Greenberg A., Rothman N.Analysis of 200 food items for 
benzo[a]pyrene and estimation of its intake in an epidemiologic study(2001)ﾊFood and 
Chemical Toxicology,ﾊ39ﾊ(5),ﾊpp.ﾊ423-436. BaP biotransformation into ultimate 
carcinogen  BPDE bonds to DNA and forms a 
bulky adduct  
 
B[a]P-Adducted Guanine 
BPDE Lesion on DNA 
Image courtesy of Peter Hoffman 
Image courtesy of Zephyris Consequences of BaP-Derived 
Adducts 
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 Two responses to BaP adduct 
 
• Local (translesion polymerase 
recruitment) 
 
• Global (reduction in DNA 
synthesis rate) S-phase checkpoint helps 
ensure replication fidelity  
• A normal response to DNA damage 
• If damage cannot be resolved, cell may 
remain quiescent or signal for apoptosis 
• Inability to activate checkpoint can 
compromise fidelity of DNA replication Phases of the Cell Life Cycle 
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G1 – Organelle synthesis 
 
S – DNA Replication 
 
G2 – Growth and protein 
synthesis 
 
M – Mitosis (Cell 
Division) BPDE-induced S-phase 
checkpoint signaling  
Apoptosis 
DNA repair 
Inhibition of firing at 
origins of  
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MMR Is S-phase checkpoint a mechanism by 
which MMR suppresses BPDE-induced 
mutations? 
• Increased mutations seen in MMR-deficient 
cells exposed to BPDE 
• BPDE induces S-phase checkpoint 
• S-phase checkpoint suppresses mutations 
• MMR is necessary for S-phase checkpoint 
induced by ionizing radiation and alkylating 
agents Hypothesis 
 
 
MMR is necessary for the 
activation of BPDE-induced S-
phase checkpoint  Predictions 
 
MMR-deficient cells will show reduced activation 
of S-phase checkpoint in response to BPDE 
exposure 
• MMR-deficient cells will display lower levels of 
PChk1 
• PChk1 can be measured using semi-
quantitative immunoblotting 
• Differences in S-phase checkpoint activation 
can be observed by flow cytometry Model system: MMR deficient and 
proficient cell lines 
HCT116+3 – 2 defective 
copies of MLH1 
(Chromosome 3) + 1 
copy of WT MLH1 + 
neomycin resistance 
gene 
WT MLH1 Chr. 
3 + neomycin 
resistance 
gene 
HCT116 – 2 
defective copies of 
MLH1 (Chr. 3) Experimental procedure 
Cultured cells: 
HCT116  
HCT116+3 
 
Whole cell 
lysates 
BPDE 
treatment 
Harvest of 
cells 
Fixing and 
PI staining 
cells 
Flow cytometry 
Protein immumoblot Predicted results 
DMSO (control) 
BPDE 
Flow cytometry 
HCT116+ch3 
DMSO 
BPDE 
HCT116 
DMSO  BPDE 
BPDE 
DMSO (control) 
BPDE 
HCT116  HCT116+ch3 
S-phase 
arrest 
PChk1 
PChk1 
Protein Immunoblots Results outline 
• Confirmation of MLH1 expression in 
cell lines 
• GAPDH loading control 
• PChk1 accumulation 
• Positive control for PChk1 
• Flow cytometry Confirmation of MLH1 expression 
in HCT116 vs. HCT116+ch3 cells 
MLH1  MSH6 
HCT116  Neg  Pos 
HCT116+3  Pos  Pos What is the upper limit of the linear 
dynamic range of GAPDH signal? 
GAPDH is not useful as a loading control when quantities greater 
than 30 μg are loaded PChk1 
Immuno-blot probed with anti-PChk1 (S345) polyclonal antibody 
BPDE-induced PChk1 accumulation 
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MLH1 Status 
Time following 
exposure 
1    2     3      4  5    6     7     8  9    10   11  12 
Def Pro Def Pro  Def Pro Def Pro  Def Pro Def Pro 
• PChk1 accumulation similar in MLH1-proficient and deficient 
cells 
• HCT116 cells show sustained PChk1 accumulation relative to 
HCT116+3 cells 
• . 
 
 BPDE-induced S-phase checkpoint 
activation in MLH1-proficient and 
deficient cells 
MLH1-Deficient                        MLH1-Proficient 
DMSO   BPDE      BPDE 
              100 nM    200 nM 
Time after 
Exposure 
(hours) 
 
24 
 
 
48 
DMSO    BPDE        BPDE 
               100 nM     200 nM Selecting gel type 
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4-12% Bis-Tris gel 
• Nonspecific signal (NS) in 4-12% Bis-
Tris gels interfered with PChk1 signal 
• Could this problem be resolved with a 
different gel? 
 
PChk1 
NS MW 
(kDa) 
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PChk1 
200 nM BPDE  DMSO (control) 
Def Pro Def  Pro  MLH1 Status 
1      2    3      4   5      6     7     8 
24  24  48  48 
Time after 
exposure  (hours) 
NS 
Def Pro Def  Pro 
7.5% Tris HCl gel used for 
identification of putative PChk1 signal 
• Similar PChk1 accumulation observed in previous gel 
• Excellent signal resolution and band separation BPDE exposed MLH1-proficient and –
deficient cells with earlier timepoints 
• Signal fairly uniform within cell lines 
• Is this signal really PChk1? Positive control for PChk1  
• HeLa cells treated with 25 μM 
etoposide or DMSO (solvent control) 
• Repeated exposure four times 
• Putative PChk1 signal weak at best 
• Results were inconsistent 
Etoposide (μM) 
  0   25   0   25 
PChk1 
NS • Preliminary results suggested MMR is 
not required for S-phase checkpoint 
activation  
•  This was not observed in subsequent 
experiments  
• Many blots had technical problems, 
some of which remain unresolved 
• Ultimately we were not sure if the 
antibody detected PChk1 
 
Protein immunoblots 
 Flow cytometry 
DNA Content (PI Fluorescence) 
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• Cells are counted and their viability determined by lasers 
• Cellular DNA content is measured by intensity of propidium 
iodide (PI) fluorescence 
•  Peak nearest origin is G1; peak twice as far from origin is G2 
• Mathematical models used to fit curves of the histogram 
• Area under curves used to estimate percentage of cells in each 
phase 
DNA Content (PI Fluorescence) HCT116+ch3 (MLH1-proficient) cells exposed to DMSO 
G1: 20% 
S: 80% 
G2:0% 
G1: 34% 
S:48% 
G2:18% 
Technical issues with flow 
cytometric analysis 
• DMSO control populations showed abnormal cell cycle 
distribution 
• Similar distribution in HCT116 (MLH1-deficient) samples HCT116+ch3 
500 nM BPDE 
HCT116+ch3 
DMSO (control) 
Comparison of flow cytometric profiles 
of MLH1-proficient cells treated with 
BPDE and DMSO 
• No consistent differences between two 
treatment groups apparent 
• MLH1-deficient cell populations gave 
similar results 
 
1  h              4  h             6 h      24 h  1  h              4  h             6 h      24 h Flow cytometry 
 
• Difficulty in fitting cell cycle patterns 
to Dean-Jett-Fox model 
• Abnormal profiles of control cells – 
likely technical issues 
• No consistent differences found 
between cell lines Conclusions 
• Preliminary results suggest sustained S-
phase arrest in MLH1-deficient cells 
• Preliminary results suggest MMR is not 
necessary for S-phase checkpoint activation 
• No pattern in S-phase checkpoint activation 
determined from flow cytometry Technical changes for future 
experiments 
• Subculture and synchronize 
cultures before exposure using 
non-chemical methods 
• Use siRNA to create MMR-deficient 
cell lines 
• Use PChk1 as positive control  
 Benefits of research 
• Identify S-phase checkpoint as a mechanism 
by which MMR suppresses mutations  
• Understand how MMR deficiency and PAH 
exposure interact to increase mutation risk 
• Identify individuals most vulnerable to 
accumulation of mutations 
• Help direct intervention efforts to vulnerable 
individuals Future research 
• Investigate other markers of S-phase 
checkpoint activation 
• Analyzing downstream effects of 
prolonged checkpoint activation 
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